Cargando…
Efficacy of Octocog Alfa (Advate) in a Child with Type 3 von Willebrand Disease and Alloantibodies
Autores principales: | Sottilotta, Gianluca, Luise, Francesca, Massara, Elisabetta, Oriana, Vincenzo, Piromalli, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615278/ https://www.ncbi.nlm.nih.gov/pubmed/28926986 http://dx.doi.org/10.3390/jcm6090085 |
Ejemplares similares
-
Anti-hemophilic factor (recombinant), plasma/albumin-free method (octocog-alpha; ADVATE(®)) in the management of hemophilia A
por: Shapiro, Amy D
Publicado: (2007) -
Octocog alfa: Lack of efficacy: case report
Publicado: (2022) -
Use of Catridecacog in a patient with severe Factor XIII deficiency undergoing surgery
por: Sottilotta, Gianluca, et al.
Publicado: (2019) -
PB2650: ALLOANTIBODIES IN VON WILLEBRAND DISEASE: ABOUT 6 CASES IN SOUTHERN TUNISIA
por: Chalbaoui, Amal, et al.
Publicado: (2023) -
Iliopsoas hematoma in patients with COVID-19 on low-molecular-weight heparin treatment
por: Sottilotta, Gianluca, et al.
Publicado: (2021)